A

    Ardelyx Inc (ARDX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.78
    -0.03 (-0.79%)

    Market Cap: $983.70M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(27/40)
    Avg Surprise
    +97.03%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.02
    Range$-0.06 - $0.02
    7 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.04+323.7%
    60d ago$0.04+323.7%
    30d ago$0.04+323.7%
    7d ago$-0.02+10.2%
    Current$-0.02
    Revenue Consensus
    $129M
    Range$120M - $135M
    11 analysts
    Dec 31, 2026
    EPS Consensus$0.01
    Range$-0.05 - $0.10
    7 analysts
    Revenue Consensus
    $146M
    Range$132M - $160M
    11 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$-0.02---
    Jun 26
    		$-0.07$-0.05-40.00%Miss+12.5%
    Mar 26
    		$-0.15$-0.14-7.14%Miss+11.8%
    Dec 25
    		$-0.00N/A+91.37%Beat-108.5%
    Sep 25
    		$-0.00N/A+94.29%Beat-17.6%
    Jun 25
    		$-0.08$-0.14+42.86%Beat-14.3%
    Mar 25
    		$-0.17$-0.07-142.86%Miss-54.5%
    Dec 24
    		$0.02$-0.00+2957.14%Beat+116.7%
    Sep 24
    		$-0.00N/A+93.20%Beat-111.3%
    Jun 24
    		$-0.07$-0.11+36.36%Beat+12.5%
    Mar 24
    		$-0.11$-0.16+31.25%Beat+15.4%
    Dec 23
    		$-0.12$-0.09-33.33%Miss-300.0%
    Sep 23
    		$0.03N/A+127.27%Beat+121.4%
    Jun 23
    		$-0.08$-0.11+27.27%Beat+57.9%
    Mar 23
    		$-0.13$-0.10-30.00%Miss+38.1%
    Dec 22
    		$0.06$-0.02+400.00%Beat+119.4%
    Sep 22
    		$-0.14$-0.17+17.65%Beat+66.7%
    Jun 22
    		$-0.19$-0.20+5.00%Beat+57.8%
    Mar 22
    		$-0.21$-0.23+8.70%Beat+38.2%
    Dec 21
    		$-0.31$-0.30-3.33%Miss+3.1%
    Sep 21
    		$-0.42$-0.35-20.00%Miss-110.0%
    Jun 21
    		$-0.45$-0.37-21.62%Miss-60.7%
    Mar 21
    		$-0.34$-0.34+0.00%Beat-36.0%
    Dec 20
    		$-0.32$-0.26-23.08%Miss-18.5%
    Sep 20
    		$-0.20$-0.30+33.33%Beat+45.9%
    Jun 20
    		$-0.28$-0.25-12.00%Miss+31.7%
    Mar 20
    		$-0.25$-0.25+0.00%Beat+40.5%
    Dec 19
    		$-0.27$-0.33+18.18%Beat+40.0%
    Sep 19
    		$-0.37$-0.37+0.00%Beat+5.1%
    Jun 19
    		$-0.41$-0.38-7.89%Miss+2.4%
    Mar 19
    		$-0.42$-0.39-7.69%Miss-16.7%
    Dec 18
    		$-0.45$-0.41-9.76%Miss-314.3%
    Sep 18
    		$-0.39$-0.43+9.30%Beat+11.4%
    Jun 18
    		$-0.42$-0.44+4.55%Beat+22.2%
    Mar 18
    		$-0.36$-0.46+21.74%Beat+39.0%
    Dec 17
    		$0.21$-0.41+151.22%Beat+131.8%
    Sep 17
    		$-0.44$-0.54+18.52%Beat+32.3%
    Jun 17
    		$-0.54$-0.65+16.92%Beat-
    Mar 17
    		$-0.59$-0.67+11.94%Beat-
    Dec 16
    		$-0.66$-0.72+8.33%Beat-
    Sep 16
    		$-0.65$-0.75+13.33%Beat-

    Key Metrics

    Valuation
    P/E Ratio-16.75EV/EBITDA130.88x
    Price/FCF-52.33xFCF Yield-1.91%
    Profitability
    Profit Margin-12.30%Operating Margin-10.30%
    ROE-38.60%ROIC-6.68%
    Financial Health
    Debt/Equity1.69xInterest Coverage-0.93x
    Current Ratio3.34xQuick Ratio3.15x
    Trading Statistics
    Beta0.73Avg Volume5.23M
    52-Week High$8.4052-Week Low$3.73

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.85
    SMA 20$4.06
    SMA 50$4.81
    SMA 200$5.90
    EMA 10$3.88
    EMA 20$4.09
    EMA 50$4.66
    EMA 200$5.48

    MACD

    Line: -0.31Signal: -0.33Hist: 0.02

    ADX

    ADX: 51.9+DI: 6.2-DI: 29.2

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$4.03

    Bollinger Bands

    Upper Band$4.83
    Lower Band$3.29
    %B Position3808%(Upper)
    Band Width0.32

    RSI (14-Day)

    Oversold
    27.8

    Momentum Oscillators

    Stoch %K23.9
    Stoch %D20.7
    Williams %R-75.6
    ROC (10d)-6.9%
    Momentum-0.28
    CCI (20d)-81.7
    MFI (14d)31.8

    Volatility Measures

    ATR (14d)$0.18(4.8%)
    StdDev (20d)0.39
    Hist Vol69.2%(High)

    Volume Flow

    VWAP$3.76
    OBV-14.3M
    AD Line-71.3M
    CMF (20d)-0.247

    Volume Metrics

    Avg Vol (20d)5.3M
    Vol Ratio0.7x
    VWMA (20d)$4.06

    Pivot Points

    R3$4.04
    R2$3.97
    R1$3.89
    Pivot Point$3.82
    S1$3.74
    S2$3.67
    S3$3.59

    Advanced Oscillators

    TSI-46.23
    Ultimate Osc37.2
    KST-220.63

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$120.88M$94.47M$125.22M$110.33M$97.66M$74.11M$116.13M$98.24M$73.22M$46.02M$34.36M$56.39M
    Cost of Revenue$5.76M$4.81M$10.85M$3.98M$12.40M$12.30M$18.26M$15.73M$9.44M$7.13M$5.08M$7.69M
    Gross Profit$115.12M$89.66M$114.37M$106.35M$85.26M$61.81M$97.86M$82.51M$63.79M$38.90M$29.29M$48.70M
    Operating Expenses$127.54M$122.45M$109.27M$101.68M$99.65M$98.16M$89.74M$80.28M$77.42M$63.57M$57.27M$41.30M
    R&D$26.10M$20.19M$22.86M$18.07M$15.67M$14.94M$13.67M$15.31M$12.76M$10.58M$9.52M$8.64M
    SG&A$101.44M$102.27M$86.41M$83.61M$83.99M$83.22M$76.07M$64.97M$64.65M$52.99M$47.75M$32.66M
    Operating Income$-12,425,000$-32,793,000$5.10M$4.67M$-14,395,000$-36,349,000$8.13M$2.23M$-13,630,000$-24,678,000$-27,986,000$7.40M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$6.22M$6.92M$7.58M$7.98M$6.58M$6.26M$5.85M$5.28M$4.90M$4.06M$2.81M$2.03M
    Income Before Tax$-16,611,000$-37,597,000$-400,000$-867,000$-19,078,000$-40,285,000$4.68M$-766,000$-16,387,000$-26,397,000$-28,469,000$6.83M
    Income Tax Expense$110,000$8,000$7,000$102,000$1,000$859,000$35,000$43,000$67,000$121,000$333,000$200,000
    Net Income$-16,721,000$-37,605,000$-407,000$-969,000$-19,079,000$-41,144,000$4.64M$-809,000$-16,454,000$-26,518,000$-28,802,000$6.63M
    EBITDA$-8,215,000$-28,184,000$10.18M$10.47M$-9,583,000$-31,285,000$13.03M$7.07M$-9,258,000$-20,151,000$-24,175,000$8.33M
    EBIT$-10,387,000$-30,681,000$7.18M$7.12M$-12,503,000$-34,023,000$10.53M$4.51M$-11,485,000$-22,339,000$-25,664,000$8.86M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ARDX

    Government Contracts

    Gov Obligations (TTM)
    $19777
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    9
    New Awards (TTM)
    8
    Avg Remaining Term
    N/A

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24526N0689Department of Veterans AffairsDepartment of Veterans Affairs$11948Jun 26, 2026
    36C24526N0339Department of Veterans AffairsDepartment of Veterans Affairs$11948Feb 20, 2026
    36C24526N0650Department of Veterans AffairsDepartment of Veterans Affairs$3999Jun 12, 2026
    36C24526N0202Department of Veterans AffairsDepartment of Veterans Affairs$2017Dec 31, 2025
    36C26125F0504Department of Veterans AffairsDepartment of Veterans Affairs$2017Sep 25, 2025
    36C24525N1015Department of Veterans AffairsDepartment of Veterans Affairs$2017Sep 19, 2025
    36C24526N0688Department of Veterans AffairsDepartment of Veterans Affairs$1991Jun 26, 2026
    36C24526N0497Department of Veterans AffairsDepartment of Veterans Affairs$1991Apr 9, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Ardelyx chief patient officer sells $41,419 in stock By Investing.com

    Laura A. Williams, Chief Patient Officer at Ardelyx, Inc. (NASDAQ:ARDX), sold 10,739 shares of company stock for $41,419 on August 21, 2026, to cover withholding taxes from RSU vesting. This transaction occurred while ARDX shares are near their 52-week low, despite analysts maintaining a "Strong Buy" consensus and InvestingPro suggesting the stock is undervalued. The sale follows Ardelyx's recent Q2 revenue increase and revised guidance for its products, which has led to increased investor interest and options trading activity.

    Investing.com Nigeria•8/26/26•
    Somewhat-Bearish

    Ardelyx CCO Eric Foster sells $33,022 in stock By Investing.com

    Ardelyx Chief Commercial Officer Eric Foster sold 8,562 shares of Ardelyx (NASDAQ: ARDX) stock for a total of $33,022 on August 21, 2026. These "sell-to-cover" transactions were executed to satisfy tax obligations from vested restricted stock units. The sale occurred while Ardelyx shares are trading near their 52-week low, despite a recent 31% increase in Q2 revenue and analyst reports suggesting the stock is undervalued.

    Investing.com Nigeria•8/26/26•
    Somewhat-Bearish

    Ardelyx CCO Eric Foster sells $33,022 in stock

    Ardelyx Chief Commercial Officer Eric Foster sold 8,562 shares of the company's common stock for $33,022 on August 21, 2026. These "sell-to-cover" transactions were executed to satisfy tax obligations upon RSU vesting, occurring as Ardelyx stock trades near its 52-week low. Despite a 31% revenue increase in Q2, the company revised its full-year guidance, leading to a stock price decline and a surge in options trading.

    Investing.com•8/26/26•
    Somewhat-Bearish

    Ardelyx chief patient officer sells $41,419 in stock

    Ardelyx's Chief Patient Officer, Laura A. Williams, sold 10,739 shares of company stock worth $41,419 to cover tax obligations from RSU vesting. This sale occurred while ARDX shares are near their 52-week low and analysts rate the stock as a "Strong Buy." The company recently reported a 31% revenue increase but revised its full-year guidance for IBSRELA and withdrew XPHOZAH's revenue target, leading to increased options trading activity.

    Investing.com•8/26/26•
    Neutral

    Ardelyx CBO Mike Kelliher sells $29,921 in shares

    Ardelyx Chief Business Officer Mike Kelliher sold 7,758 shares of ARDELYX, INC. stock for approximately $29,921 on August 21, 2026. These sales were "sell-to-cover" transactions to meet tax obligations on vested restricted stock units. The company recently reported a 31% revenue increase in Q2 2026, but adjusted its full-year guidance for its IBSRELA product and withdrew its XPHOZAH revenue target, leading to increased options trading activity skewed towards put options.

    Investing.com•8/26/26•
    Somewhat-Bearish

    Frequently Asked Questions About ARDX

    Does ARDX pay dividends?
    Ardelyx Inc (ARDX) does not currently pay a regular dividend.
    What is ARDX's market cap?
    Ardelyx Inc (ARDX) has a market capitalization of $983.70M with a current stock price of $3.78.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In